Mar 30, 2022 / 12:00PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Incorporated Fourth Quarter and Fiscal Year 2021 Earnings Conference Call. My name is [Olivia] and I will be your conference operator today. This call is being recorded. I would now like to turn the presentation over to your speaker host for today's call, Mr. Daniel Kontoh-Boateng, Investor Relations for Cognition Therapeutics. Please proceed.
Daniel Kontoh-Boateng - Investor Relations, Cognition Therapeutics, Inc - Tiberend Strategic Advisors, Inc.
Good morning and thank you for participating in Cognition Therapeutics conference call today. With me today are Lisa Ricciardi, President and Chief Executive Officer of Cognition, and Jim O'Brien, Chief Financial Officer of Cognition.
By now you should have the press release we issued earlier. If not, it is available on the Investor Relations page of our website at cogrx.com. We encourage everyone to read this morning's press release as well as Cognition's Annual Report on Form 10-K, which is now filed with the SEC.
Q4 2021 Cognition Therapeutics Inc Earnings Call Transcript
Mar 30, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers